Effect of certain drugs on perfused human placenta. 8. Angiotensin-II antagonists.
D000085:Acetates / Q000494:pharmacology; D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D001285:Atropine / Q000494:pharmacology; D001795:Blood Pressure Determination; D003035:Cobalt / Q000494:pharmacology; D003042:Cocaine / Q000494:pharmacology; D003533:Cyproheptadine / Q000494:pharmacology; D003983:Dibenzylchlorethamine / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D000431:Ethanol / Q000494:pharmacology; D005260:Female; D005663:Furans / Q000494:pharmacology; D006018:Glycols / Q000494:pharmacology; D006801:Humans; D006830:Hydralazine / Q000494:pharmacology; D066298:In Vitro Techniques; D007548:Isosorbide Dinitrate; D009132:Muscles / Q000494:pharmacology*; D009566:Nitrates / Q000494:pharmacology; D009573:Nitrites / Q000494:pharmacology; D005996:Nitroglycerin / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010477:Perfusion; D010646:Phentolamine / Q000494:pharmacology; D010920:Placenta / Q000187:drug effects*; D011247:Pregnancy; D012964:Sodium; D013565:Sympatholytics / Q000494:pharmacology*; D013644:Tartrates / Q000494:pharmacology; D014043:Tolazoline / Q000494:pharmacology
D000085:Acetates; D005663:Furans; D006018:Glycols; D009566:Nitrates; D009573:Nitrites; D013565:Sympatholytics; D013644:Tartrates; D000804:Angiotensin II; D006830:Hydralazine; D003533:Cyproheptadine; D003035:Cobalt; D000431:Ethanol; D003983:Dibenzylchlorethamine; D004176:Dipyridamole; D001285:Atropine; D012964:Sodium; D014043:Tolazoline; D010208:Papaverine; D005996:Nitroglycerin; D003042:Cocaine; D007548:Isosorbide Dinitrate; D010646:Phentolamine